The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Wireopedia is an automated news feed. The Wireopedia AI pulls from sources with different views so you can see the various sides of different arguments and make a decision for yourself. Wireopedia will be firmly committed to the public interest and democratic values.
Privacy Policy Terms and Conditions
© 2024 WIREOPEDIA - All right reserved.
© 2024 WIREOPEDIA - All right reserved.